Back to Journals » Therapeutics and Clinical Risk Management » Volume 6

Selecting GLP-1 agonists in the management of type 2 diabetes: differential pharmacology and therapeutic benefits of liraglutide and exenatide

Total article views   HTML views PDF downloads Totals
12,563 Dovepress* 12,563+ 3,007 15,570
Totals 12,563 3,007 15,570
*Since 31 August 2010
+Since July 2016

View citations on Google Scholar